CHENNAI: Lung cancer continues to be a major contributor to cancer-related deaths globally and poses a significant challenge ...

Having an understanding of the progression of lung cancer and the treatment methods helps the patients and their families to ...

As technology and genomic research progress, these diagnostics may become more accessible, enabling broader adoption across ...

Project EVOLVE findings show how AI-driven real-world data analysis, combined with targeted educational interventions, can ...

Prevention, screening and treatment advances combined stopped 5.94 million deaths from cancer in the United States from 1975 through 2020.

The investigational oral HER2-specific tyrosine kinase inhibitor would address an unmet need in non–small cell lung cancer.

AstraZeneca and Daiichi Sankyo shared the pooled analysis behind the refiling of their TROP2 antibody-drug conjugate (ADC) ...

Managed Healthcare Executive provides C-suite executives at health plans and provider organizations with news, analysis, ...